KISSEI PHARMACEUTICAL CO., LTD.
キッセイ薬品工業株式会社
Valuation
Fundamental ratios for the latest reported period.
Ticker: 4547
FY2025 (Mar 2026) · J-GAAP · consolidated Source: filing S100YFN3
FY = fiscal year, named by the calendar year it starts in; the month in brackets is when it ends (FY2025 ends Mar 2026 for a March year-end). FY2025 (Mar 2026) runs Apr 1, 2025 – Mar 31, 2026.
| Gross margin | 47.0% |
|---|---|
| Operating margin | -3.0% |
| Net margin | 14.1% |
| Return on equity | 6.3%Includes one-off items (e.g. gains on negative goodwill) |
| Return on assets | 5.3% |
| Revenue growth (YoY) | 10.3% |
| EPS (basic) | ¥331.54 |
| EPS growth (YoY) | 20.9% |
| Current ratio | 5.30x |
| Equity ratio | 83.7% |
| Book value / share | ¥5,552.11 |
| Free cash flow | −¥7.1B |